Shilpa Medicare Ltd recorded volume of 29.7 lakh shares by 14:14 IST on NSE, a 47.58 times surge over two-week average daily volume of
Of Rs 1.1 per share
Hikal Ltd, eClerx Services Ltd, Sterlite Technologies Ltd and Sharda Cropchem Ltd are among the other gainers in the BSEs A group today
Shilpa Medicare Ltd witnessed volume of 75992 shares by 10:47 IST on BSE, a 12.45 times surge over two-week average daily volume of 610
Sales rise 63.73% to Rs 340.60 crore
On 23 May 2022
With four observations
The Company will be submitting the responses to USFDA observations within stipulated timeline and implement the corrective actions to a
Biosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
The rating on fund-based working capital limits has been affirmed at IND A+/Stable/IND A1.
Per Order for ETF & Mutual Funds Brokerage
Per Order for Delivery, Intraday, F&O, Currency & Commodity